This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Philips' (PHG) Q1 Earnings Down Y/Y on Supply Chain Constraints
by Zacks Equity Research
Koninklijke Philips' (PHG) Q1 top- and bottom-line results reflect negative impact of supply chain constraints and consequences of the Respironics field action.
Philips' (PHG) Innovative Product Suite to Cheer Investors
by Zacks Equity Research
Philips (PHG) launches two major cardiological innovations at ACC 2022, adding strength and depth to its existing healthcare portfolio.
Philips' (PHG) Lung Suite 3D Imaging Solution Gains Traction
by Zacks Equity Research
Philips' (PHG) innovative lung cancer diagnosis and treatment solution, Philips Lung Suite, is witnessing rapid adoption by clinical partners globally
Philips (PHG) Ties Up With Nuvo Group to Boost Maternal Care
by Zacks Equity Research
Philips (PHG) collaborates with Nuvo to develop maternity care services with digital solutions and eco-system building in rural areas
Philips' (PHG) Collaboration Live Gets Nod for Remote Diagnosis
by Zacks Equity Research
Koninklijke Philips' (PHG) Collaboration Live integrated tele-ultrasound receives the expanded U.S. Food & Drug Administration 510(k) clearance for remote diagnostic use on additional mobile platforms.
The Zacks Analyst Blog Highlights: Roche Holding, Pfizer, Baxter International, STMicro and Philips
by Zacks Equity Research
Roche Holding, Pfizer, Baxter International, STMicro and Philips are included in this analyst blog.
Company News for Jan 25, 2022
by Zacks Equity Research
Companies in The News Are: PHG,CBU,BOH,NWBI
Phillips (PHG) Blends 3D Mapping With Zenition, Aids Prospects
by Zacks Equity Research
Phillips (PHG) integrates AI and 3D mapping capabilities it its Mobile C-Arm System, Zenition, enhancing its diagnostic imaging portfolio.
Philips' (PHG) Q4 Earnings Hit By Supply-Chain Issues, Recall
by Zacks Equity Research
Philips (PHG) fourth-quarter and 2021 results suffer from supply-chain constraints and adverse impact of the Respironics recall.
New Strong Sell Stocks for January 7th
by Zacks Equity Research
APTV, PHG, and SNCY have been added to the Zacks Rank #5 (Strong Sell) List on January 7, 2022
Phillips' (PHG) Partner Base Expansion Drives Prospects
by Zacks Equity Research
Phillips (PHG) signed a long-term agreement with IJsselland Hospital to facilitate digitization and innovation in healthcare.
Philips (PHG) to Buy Vesper Medical, Expand Vascular Portfolio
by Zacks Equity Research
Philips (PHG) is set to acquire Vesper Medical to strengthen its vascular devices portfolio and customer base.
Philips (PHG)-Cognizant Collaborate to Develop Health Solutions
by Zacks Equity Research
Philips (PHG) is collaborating with Cognizant to develop health solutions that will help healthcare and life science companies provide improved patient care and accelerate clinical trial procedure.
PHG or SYK: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
PHG vs. SYK: Which Stock Is the Better Value Option?
Koninklijke Philips (PHG) is Oversold: Can It Recover?
by Zacks Equity Research
Koninklijke Philips (PHG) has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock.
Company News for Jun 15, 2021
by Zacks Equity Research
Companies In The News Are: RIDE, PHG, AVXL, RDS.A
ResMed (RMD) Rallies as Philips Falters on Mass Product Recall
by Zacks Equity Research
The full U.S. launch of ResMed (RMD) AirSense 11 is expected any time in 2021, which might receive bigger market acceptance capitalizing on its current peer position.
Philips (PHG) Recalls CPAP, Ventilators Used for Sleep Apnea
by Zacks Equity Research
Philips (PHG) is recalling some Bi-Level PAP, CPAP, and mechanical ventilator devices in the United States due to health risks.
Philips' (PHG) SmartCT 3D-Imaging Software Gets FDA Approval
by Zacks Equity Research
Philips (PHG) SmartCT application software, which is a key component of the Azurion Image Guided Therapy System, has been granted clearance by the U.S. FDA.
Looking for a Growth Stock? 3 Reasons Why Philips (PHG) is a Solid Choice
by Zacks Equity Research
Philips (PHG) possesses solid growth attributes, which could help it handily outperform the market.
Philips' (PHG) Q4 Earnings up Y/Y on Connected Care Growth
by Zacks Equity Research
Koninklijke Philips' (PHG) Q4 top- and bottom-line results reflect robust performance in the Connected Care business as well as cost savings.
Philips (PHG) Set to Acquire Capsule Technologies for $635M
by Zacks Equity Research
Philips (PHG) is set to acquire Andover, MA-based Capsule Technologies that will expand its total addressable market and customer base.
3 Electronics Stocks to Buy From a Prospering Industry
by Aniruddha Ganguly
Electronics stocks like PHG, CARR and GRMN are likely to benefit from investments in infrastructure and an expanded capacity despite the negative impact of the coronavirus pandemic.
Digital Health M&As Gain Precedence in the New Normal
by Debanjana Dey
The booming digital health space has been witnessing significant M&A activities amid the pandemic.
Consumer Electronic Goods Poised to Grow: 5 Winners
by Zacks Equity Research
Demand for consumer electronic goods like desktops, air purifiers and video streaming have gone up as more people are saying at home. This has been helping companies like Apple (AAPL), Dell Technologies (DELL) and Carrier Global (CARR) and Koninklijke Philips (PHG).